Effectiveness of Pharmacotherapy for Body Dysmorphic Disorder: A Chart-Review Study
The DOI matches its Crossref record.
Abstract
BACKGROUND: Research on the pharmacotherapy of body dysmorphic disorder (BDD) is limited. No placebo-controlled, continuation, maintenance, or discontinuation studies have been published. Only one augmentation study has been published. METHOD: In this chart-review study of 90 patients with DSM-IV BDD treated for up to 8 years by the first 2 authors (K.A.P., R.S.A.) in their clinical practice, response to a variety of medications, including augmentation strategies, was assessed. The relapse rate with medication discontinuation was also determined. RESULTS: All subjects received a serotonin reuptake inhibitor (SRI), with 63.2% (55/87) of adequate SRI trials resulting in improvement in BDD symptoms; similar response rates were obtained for each type of SRI. Discontinuation of an effective SRI resulted in relapse in 83.8% (31/37) of cases. Response rates to selective SRI augmentation were clomipramine, 44.4% (4/9) of trials; buspirone, 33.3% (12/36) of trials; lithium, 20.0% (1/5); methylphenidate, 16.7% (1/6); and antipsychotics, 15.4% (2/13) of trials. CONCLUSION: These findings from a clinical setting suggest that a majority of BDD patients improve with an SRI and that all SRIs appear effective. Certain SRI augmentation strategies may be beneficial. The high relapse rate with SRI discontinuation suggests that long-term treatment is often necessary. These preliminary findings require confirmation in placebo-controlled efficacy studies and effectiveness studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Body Dysmorphic Disorder and Cosmetic Surgery
Crerand, C. E., Franklin, M. E., & Sarwer, D. B. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000242500.28431.24 · Cited by 265
Phillips, K. A., & Hollander, E. (2008) · Body Image · doi:10.1016/j.bodyim.2007.12.003 · Cited by 214
Self-citationPsychodermatology:A guide to understanding common psychocutaneous disorders
Jafferany, M. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0306 · Cited by 200
Phillips, K. A., Menard, W., Quinn, E., Didie, E. R., & Stout, R. L. (2013) · Psychological Medicine · doi:10.1017/s0033291712001730 · Cited by 174
“Because serotonin reuptake inhibitors (SRIs) are considered the first-line pharmacotherapy for BDD (NICE, 2006; Phillips et al. 2008; Ipser et al. 2009), SRI trials were classified as ‘optimal ’ or ‘minimally adequate ’ based on previously suggested guidelines (Phillips et al. 2001).”
BackgroundSelf-citationPhillips, K. A., Keshaviah, A., Dougherty, D. D., Stout, R. L., Menard, W., & Wilhelm, S. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091243 · Cited by 75
Self-citation
Metadata
- Authors
- Phillips, K. A., Albertini, R. S., Siniscalchi, J. M., Khan, A., & Robinson, M.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-09-15
- Volume
- 62
- Issue
- 9
- Pages
- 721-727
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2041254461
- Cited by
- 106
- References
- 0
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of Pharmacotherapy for Body Dysmorphic Disorder: A Chart-Review Study. https://app.cochat.ai/papers/10.4088/jcp.v62n0910
- The paper
- Phillips, K. A., Albertini, R. S., Siniscalchi, J. M., Khan, A., & Robinson, M. (2001). Effectiveness of Pharmacotherapy for Body Dysmorphic Disorder: A Chart-Review Study. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v62n0910
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.